2008 Washington State Biomedical Device Summit

WBBA is collaborating with several organizations to host the 2008 Washington State Biomedical Device Summit. Focused solely on the region’s medical device sector, the May 15 Summit will attract 200 executives from the medical device industry, researchers, economic development professionals and media. The event will feature a report on key findings of a sector study, a panel discussion with executives from the region’s industry, the launch of the Biomedical Device Innovation Partnership Zone, a showcase medical device products developed or being developed in Washington state and a reception. WBBA’s partners on this effort are enterpriseSeattle, the Economic Development Council of Snohomish County, City of Bothell, University of Washington Bothell, the Prosperity Partnership and the Washington Technology Industry Association. The event is Thursday, May 15 from 4-7 pm, at UW Bothell. WBBA members receive discounted member rate.
Space is Limited - Register Today!
|
|
Register Now! WBBA Golf Invitational August 22
Play golf with 100 + of your best bioscience friends on Friday, August 22 at the 4th Annual WBBA Golf Invitational. Mark your calendar for a morning on the greens and a relaxing luncheon to follow at beautiful Trilogy Golf Course in Redmond. We’d like to recognize our sponsors to date: Townsend and Townsend and Crew LLP (Premier Sponsor); Seed I.P. Law Group, PLLC (Photo Sponsor); Lease Crutcher Lewis (Beverage Cart Sponsor); Skilled Hole Sponsors AH&T and Wells Fargo Insurance Services and Hole Sponsors ABD Insurance, BNBuilders, Inc., Parker/Smith/Feek, and Prudential Cleanroom Services.
More sponsorships are available, so check for sponsorships and reserve online or contact pamlove@washbio.org for more information. Register to play: $225 individual; $900 foursome. For more information contact patti@washbio.org.
Register Today!
Sponsorship Opportunities
|
Local News...
Free News Release Posting & Archiving Service
- QLT reports initial proof-of-concept data for punctal plug delivery technology QLT Inc. announced results from a proof-of-concept trial conducted by QLT’s wholly-owned subsidiary, QLT Plug Delivery, of its punctal plug drug delivery technology. The results demonstrated that QLT’s drug elution technology was effective in controlling intraocular pressure and was well tolerated.
QLT Inc. May 12, 2008
- Lilly completes final phase of its Indianapolis Biotechnology Complex Eli Lilly and Company announced completion of the final phase of its $1 billion effort to further strengthen the company's biotechnology research and development capabilities.
Eli Lilly and Company May 12, 2008
- Forbes Medi-Tech announces completion of $3.8 million non-dilutive funding transaction Forbes Medi-Tech announced that, as part of its continuing reorganization plan, it has completed the previously announced transaction with a private investor to reorganize Forbes Medi-Tech Operations, a wholly owned subsidiary of Forbes.
Forbes Medi-Tech, Inc. May 12, 2008
- BioMS Medical provides update on pipeline products BioMS Medical announced an update on its pipeline products, HYC750 and development with BioCyDex. The Company has entered into a Royalty and Assignment Agreement with Orcrist Bio. for HYC750.
BioMS Medical Corp. May 09, 2008
- Bayer and Regeneron start additional Phase 3 Study for VEGF Trap-Eye Bayer HealthCare and development partner Regeneron Pharmaceuticals announced that the first patient has been dosed in the new VIEW 2 trial, a second Phase 3 clinical study in a development program evaluating VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration.
Bayer May 08, 2008
More... | Submit News Release | National News
|